 | This articlerelies excessively onreferences toprimary sources. Please improve this article by addingsecondary or tertiary sources. Find sources: "Dokumeds" – news ·newspapers ·books ·scholar ·JSTOR(March 2010) (Learn how and when to remove this message) |
| Company type | Private |
|---|---|
| Industry | |
| Founded | 1995; 30 years ago (1995) |
| Headquarters | Riga,Latvia |
| Services | Support services for pharmaceutical, biotech and medical companies |
| Revenue | 8,307,219 euro (2022)  |
| 867,980 euro (2022) | |
| Total assets | 5,032,347 euro (2022) |
Number of employees | 63 (2022) |
| Website | www |
DOKUMEDS is EuropeanClinical Research Organization (CRO) providing a comprehensive range of services forclinical research focused primarily on Phase I-IVclinical trials and development to the pharmaceutical, biotechnology and medical device industry. Established in 1995, Dokumeds has been expanding its coverage and services significantly over 25 years of operations. Gradual geographical and operational coverage expansion has correlated with company staff growth and lowering of employee turnover. Nowadays Dokumeds is a leading international CRO with operational capabilities in 30+ countries in Europe, Africa, and other regions.
Apart from a full cycle of services for Phase I – IV clinical development programs, Dokumeds functional service provision capabilities are:[citation needed]
DOKUMEDS has offices in:
DOKUMEDS has been operating in the field of clinical trials for 25 years, founded in 1995.[1][2]